News & Analysis on Clinical Trial Services & Contract Research And Development
ITI Life Sciences launches the first R&D programme to develop 3-dimensional cell-based assays with fluorescence lifetime detection technology that aims to address a significant bottleneck in the drug discovery and development process.
According to a recent survey, leading pharmaceutical firms claim that despite the decline in R&D productivity, scientists are working harder and completing more projects.
FDA's approval of Sanofi-Aventis' Eloxatin (oxaliplatin) is unlikely to increase the drug's patient base, but the new formulation should consolidate Sanofi-Aventis' position as the largest pharmaceutical firm in Europe and a major player in...
The pharmaceuticals sector has been highlighted by the UK government's Cabinet Office as one of its priority projects in a review of business regulation.
Pall is gearing up to launch a new filter technology in Europe that can remove prions - the infectious agents that cause mad cow disease and its human form Creutzfeldt-Jakob disease (vCJD) - from blood and blood products.
Emerson Process Management has launched a new sensor device to help pharmaceutical companies ensure that their clean-in-place (CIP) procedures - essential for aseptic processing - are working effectively.
Invitrogen announced it is to acquire Dynal Biotech, the molecular separation and purification technology company. The deal will provide Invitrogen with bead-based isolation technologies that targets key medical research issues.
The European approval of a new high-potency vaccine for hepatitis B virus (HBV) marks the debut on the marketplace of a new adjuvant ingredient that can significantly improve the effectiveness of immunisations, reports Phil Taylor.